Latest from PAN
PAN CEO moderates telemedicine panel at ATA Policy Summit
PAN CEO Amy Comstock Rick moderated a panel at the American Telemedicine Association (ATA) Policy Summit that brought together health care providers, regulators, and patient groups to discuss the latest developments affecting telemedicine with key elected and federal officials. Learn More. 
Medicare Therapy Caps: What you need to know and why
Medicare coverage of physical, occupational, and speech language therapies is an important issue for many with chronic illnesses who rely upon these services for better quality of life. PAN continues to work to ensure that these medically-necessary services are available for people with Parkinson’s. Learn more. 
Take Action With PAN!
Encourage your Members of Congress  to join the Congressional Caucus on Parkinson’s Disease and increase political leadership for the Parkinson’s community on Capitol Hill.
Contact your Representative,  and ask him or her to support the Veterans E-Health and Telemedicine Support (VETS) Act of 2013 (H.R. 2001), a critical step forward in breaking down barriers to telemedicine for everyone.
In The News
One-two punch vs. Parkinson's: meds and a machine - Omaha World-Herald
An Omaha scientist will start a human trial this summer involving the novel use of a drug that he hopes will halt the progress of Parkinson's disease. More… 
Meta-analysis on pesticides, Parkinson's - Agri-View
A large analysis of more than 100 studies from around the world shows that exposure to pesticides and solvents is likely associated with a higher risk of developing Parkinson's disease. More… 
Parkinson's Treatment With Pluripotent Stem Cell-Derived Neurons Shows ... - Medical News Today
In an animal experiment using primates modeled with Parkinson's disease, transplanting human embryonic stem cells revealed "robust survival" of the cells after six weeks. More… 
Link between allergic rhinitis and Parkinson's disease - The Almagest
Previous research has shown that those taking non-steroidal anti-inflammatory drugs, like ibuprofen, are less likely to develop Parkinson's disease. More… 
BIOFocus receives grant to develop new Parkinson’s therapies - Business Weekly
Drug discovery facilitator BioFocus has received a grant from The Michael J. Fox Foundation to develop novel therapeutics for Parkinson's disease. More… 
Parkinson's disease study looks for people over 60 who've lost sense of smell - New Haven Register
The Institute for Neurogenerative Disorders in New Haven, CT is part of a study hoping to determine whether the loss of the sense of smell is a biomarker for Parkinson’s disease. More…